Home » FDA Grants Fast-Track Designation to ELND005
FDA Grants Fast-Track Designation to ELND005
The FDA awarded fast-track designation to Elan’s ELND005. The drug, which is still in multiple trials, is meant to reduce agitation and aggression that are often part of Alzheimer’s disease.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May